Zhengye biotechnology holding limited announces closing of initial public offering

Jilin, china, jan. 08, 2025 (globe newswire) -- zhengye biotechnology holding limited (nasdaq: zybt) (the "company" or "zhengye"), a veterinary vaccine manufacturer that encompasses research, development, manufacturing, and sales of veterinary vaccines, with a focus on livestock vaccine in china, today announced the closing of its initial public offering (the "offering") of 1,500,000 ordinary shares at a public offering price of us$4.00 per ordinary share. the ordinary shares have been approved for listing on the nasdaq capital market and commenced trading on january 7, 2025 under the ticker symbol "zybt."
ZYBT Ratings Summary
ZYBT Quant Ranking